Plastic Logic selects new tech VP; Ubisense wins US bus contract; Sage signs up ITV for Krypton Factor relaunch

eReader developer Plastic Logic Ltd said Martin Jackson had been appointed as VP Technology to head its Cambridge R&D centre. Mr Jackson has more than 20 years' executive and technical management experience in leading corporate and technical strategies in the communications, consumer electronics, and semiconductor industries.

The co-founder of four start ups, Mr Jackson most recently served as CTO for Artimi Ltd, a Cambridge-based semiconductor firm leading the delivery of high speed wireless connectivity in portable consumer electronics devices. At Artimi, he was responsible for the development and delivery of the industry's first demonstration of next-generation High-Speed Bluetooth over Ultra Wideband at 3 GSM.

Previously, he was CTO at Frontier Silicon.. He also served as CTO of DSL semiconductor company GlobespanVirata.

* * * *

Ubisense, provider of precise Real Time Location Systems, said it had been selected by Metro Transit of the Twin Cities to improve the operational efficiency of scheduling and dispatching more than 900 buses at five garages in the Minneapolis-St. Paul area of the US.

In 2003, Metro Transit deployed an Automatic Vehicle Location system, which uses global positioning system to track buses, providing information to operators and transit users. When the bus enters the garages, however, they are parked at specific positions in one of up to 30 lanes, divided into several bays. With the installation of the Ubisense RTLS, tags placed on the buses' rooftops send signals to a sensor network inside the garages providing a location to within one meter of accuracy, allowing the automatic determination of which position within a particular bay and lane a bus was parked. If a bus moves to another location, this information is automatically updated and sent back to the system. Ubisense will provide the location of the bus to Metro Transit's scheduling and dispatching system, instantly providing the dispatcher with the location of each bus in the garage at all times, removing errors in bus assignment at the beginning of each period of service.

* * * *

Cambridge Consultants announced agreement to license its Conix Dry Powder Inhaler (DPI) technology platform to 3M Drug Delivery Systems.

The deal gives 3M an exclusive technology license and purchase agreement. Conix can be used in a range of devices, from single dose mass inoculation through to a multi-unit dose suitable for routine therapies, such as asthma and COPD. The deal gives 3M complete access to the technology enabling them to deliver the next generation of DPIs.

* * * *

Sage (UK) Ltd, the business software and services provider, announced an agreement with ITV1 to relaunch The Krypton Factor to run alongside the first part of its new nationwide campaign to identify Britain's Business IQ attributes. As part of a much wider campaign, managed by content agency Drum PHD, the Sage and ITV partnership is set to result in the biggest advertiser funded programme ITV has ever commissioned and the first one to appear in ITV1's prime time schedule.

Sage's Business IQ campaign aims to understand, explore and celebrate the qualities that make people in business more likely to succeed. Sage has signed a deal with ITV1 to fund the production of The Krypton Factor. It includes integrated sponsorship credits around the show with exclusive additional content to be available online and across ITV's other digital platforms.

Head of Brand Communications Joanna Elliott said: "The advertising funded programme model works for us because it is one high impact tactic that can be integrated into a much bigger marketing strategy."

 



Previous articles
Xaar dives as it warns 2006 profits worse than expected
Fur flies at Meldex as Board fights off dissident shareholder
Dialight 07 revenue hit by dollar weakness but delivers expected profits; mulls divesting LED components unit
Meldex sells Dexo for €8.5m in ‘distressed sale’ to repay bankers; well advanced in restructure
Minster Pharma’s phase IIb trial of novel migraine drug fails; will examine other applications
Acambis’ shares gain on US’ FDA approval of its smallpox vaccine
Briefs: Agilent, Spirent join CSR in EGPS Forum; Stem Cell Sciences launches iStem
Abcam in early talks about a potential takeover offer
After a tough year MMI raises £1m; reports narrower losses; to change name to reflect new strategy
Cybit reports record results: substantial rises in revenue, pretax profits
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Geneservice


Roger Turner BSc, FCA, F Inst D
Finance and Commercial Director


Geneservice Ltd is a contract research organisation and biological resource centre. In May 2005 it was formed as a limited company in a management buyout of MRC geneservice. Geneservice makes available genomic and proteomic libraries from a wide range of organisms in various formats (e.g. single clones,

[Geneservice's profile]


Top20 Index




Currently: 161